Skip to main content
Equibles

Deep Track Capital, LP

Position in IONS — Ionis Pharmaceuticals Inc

CIK 1856083 GREENWICH, CT
Back to IONS Full portfolio

Position in IONS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$174,438,000
+$28,012,500 QoQ
Shares Held
2,200,000
+12.8% QoQ
Ownership
1.32%
of shares outstanding
% of Portfolio
2.66%
of 13F equity value
Holder Rank
#16
of 514 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IONS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Deep Track Capital, LP holds $5,341,997,223 across 58 Biotechnology names. IONS ranks #12 (3.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IMVT
Immunovant, Inc.
 9,341,151 $359,914,548
2 GPCR
Structure Therapeutics Inc.
 4,740,072 $254,399,664
3 PCVX
Vaxcyte, Inc.
 4,300,000 $249,959,000
4 ALNY
Alnylam Pharmaceuticals, Inc.
 825,000 $248,349,750
5 MANE
Veradermics, Inc
 2,000,000 $245,880,000
6 TARS
Tarsus Pharmaceuticals, Inc.
 3,666,768 $230,786,377
7 OCUL
Ocular Therapeutix, Inc
 19,686,282 $193,319,289
8 BMRN
Biomarin Pharmaceutical Inc
 3,307,481 $189,254,062

All Filings in IONS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $174,438,000 2,200,000
2026-03-31 $146,425,500 1,950,000
2025-12-31 $134,487,000 1,700,000
2025-09-30 $249,128,780 3,808,144
2025-06-30 $193,264,903 4,891,544
2025-03-31 $137,702,125 4,564,207
2024-12-31 $67,610,122 1,933,928
2024-09-30 $88,132,000 2,200,000
2024-06-30 $95,320,000 2,000,000
2024-03-31 $59,540,141 1,373,475
2023-12-31 $63,190,350 1,249,068
2023-09-30 $128,553,369 2,834,069
2023-06-30 $116,281,851 2,834,069
2023-03-31 $101,289,626 2,834,069
2022-12-31 $45,542,046 1,205,773